Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease

Clinical Medicine and Research

Volumn 4, Issue 4, 2006, Pages 322-325

  Pellecchia, Maria Teresa ^a   Pivonello, Rosario ^a   Colao, Annamaria ^a   Barone, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Arginine; Clonidine; Growth hormone; Multiple system atrophy; Parkinson's disease

Indexed keywords

ARGININE; CLONIDINE; GROWTH HORMONE;

BRAIN REGION; DIFFERENTIAL DIAGNOSIS; HUMAN; PARKINSON DISEASE; PROVOCATION TEST; REVIEW; SHY DRAGER SYNDROME;

EID: 33846498493     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.4.4.322     Document Type: Review

References (24)

1. Gudmundsson KR. A clinical survey of parkinsonism in Iceland. Acta Neurol Scand 1967;43:1-61.
2. Kessler II. Epidemiologic studies of Parkinson's disease. 3. A community-based survey. Am J Epidemiol 1972;96:242-254.
3. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976;53:81-102.
4. Forno LS. The Lewy body in Parkinson's disease. Adv Neurol 1987;45:35-43.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
6. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders III. London, UK: Butterworth-Heinemann; 1994. 262-281.
7. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100.
8. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004;3:93-103.
9. Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298.
10. Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 1999;79:511-607.
11. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19:717-797.
12. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-381.
13. Kimber JR, Watson L, Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997;349:1877-1881.
14. Clarke CE, Ray PS, Speller JM. Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease. Lancet 1999;353:1329-1330.
15. Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? J Neurol 2000;247:853-856.
16. Strijks E, van't Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. J Neurol 2002;249:1206-1210.
17. Lee EA, Kim BJ, Lee WY. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography. Mov Disord 2002;17:1242-1247.
18. Benarroch EE, Smithson IL, Low PA, Parisi JE. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol 1998;43:156-163.
19. Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia. Clin Endocrinol (Oxf) 2005;62:428-433.
20. Tago H, McGeer PL, Bruce G, Hersh LB. Distribution of choline acetyltransferase-containing neurons of the hypothalamus. Brain Res 1987;415:49-62.
21. Caffe AR. Architecture of the mammalian pituitary cholinergic system with observations on a putative blood acetylcholine sensor. Histol Histopathol 1996;11:537-551.
22. Spokes EG, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979;43:59-82.
23. Norbiato G, Bevilacqua M, Righini V, Chebat E, Vago T, Bertora P, Castelli L, Mangoni A. Altered vasopressin response to metoclopramide in multiple system atrophy: evidence of a cholinergic defect in the hypothalamus. Acta Neurol Scand 1992;85:299-303.
24. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002;59:944-946.